Sleep Apnoea Adverse Effects on Cancer: True, False, or Too Many Confounders?
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Obstructive sleep apnoea (OSA) is a prevalent disorder associated with increased cardiovascular, metabolic and neurocognitive morbidity. Recently, an increasing number of basic, clinical and epidemiological reports have suggested that OSA may also increase the risk of cancer, and adversely impact cancer progression and outcomes. This hypothesis is convincingly supported by biological evidence linking certain solid tumours and hypoxia, as well as by experimental studies involving cell and animal models testing the effects of intermittent hypoxia and sleep fragmentation that characterize OSA. However, the clinical and epidemiological studies do not conclusively confirm that OSA adversely affects cancer, even if they hold true for specific cancers such as melanoma. It is likely that the inconclusive studies reflect that they were not specifically designed to test the hypothesis or because of the heterogeneity of the relationship of OSA with different cancer types or even sub-types. This review critically focusses on the extant basic, clinical, and epidemiological evidence while formulating proposed directions on how the field may move forward.
Briancon-Marjollet A, Joyeux-Faure M, Ben Messaoud R, Bailly S, NGo V, Colombet S ERJ Open Res. 2024; 10(4).
PMID: 38978551 PMC: 11228602. DOI: 10.1183/23120541.00930-2023.
Impact of sleep on gastrointestinal cancer.
Lo J, Taweesedt P, Kawai M World J Clin Oncol. 2024; 15(6):677-683.
PMID: 38946837 PMC: 11212604. DOI: 10.5306/wjco.v15.i6.677.
OConnor-Reina C, Rodriguez Alcala L, Ignacio J, Garcia-Iriarte M, Carrasco Llatas M, Casado Morente J Eur Arch Otorhinolaryngol. 2024; 281(6):3131-3141.
PMID: 38206392 DOI: 10.1007/s00405-023-08446-3.
Multi-Omics Analysis of Circulating Exosomes in Adherent Long-Term Treated OSA Patients.
Khalyfa A, Marin J, Sanz-Rubio D, Lyu Z, Joshi T, Gozal D Int J Mol Sci. 2023; 24(22).
PMID: 38003263 PMC: 10671639. DOI: 10.3390/ijms242216074.
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.
Lazarus E, Bays H Obes Pillars. 2023; 3:100026.
PMID: 37990728 PMC: 10661911. DOI: 10.1016/j.obpill.2022.100026.